Accessibility Menu
 

American Oriental Bioengineering

(OTC) AOBI

Current Price$0.00
Market Cap$100
Since IPO (2002)-100%
5 Year-100%
1 Year+140%
1 Month+0%

American Oriental Bioengineering Financials at a Glance

Market Cap

$100

Revenue (TTM)

$121.58M

Net Income (TTM)

$91.02M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1048.91 (High)

Price

$0.00

Volume

4

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

AOBI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About American Oriental Bioengineering

Industry

Personal Products

Headquarters

Beijing, 100176, CN

AOBI Financials

Key Financial Metrics (TTM)

Gross Margin

31%

Operating Margin

-38%

Net Income Margin

-41%

Return on Equity

0%

Return on Capital

-16%

Return on Assets

-13%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

73.00K

Volume

4

Short Interest

0.00%

Avg. Volume

0.3

Financials (TTM)

Gross Profit

$44.36M

Operating Income

$54.97M

EBITDA

$39.64M

Operating Cash Flow

$46.45M

Capital Expenditure

$26.14M

Free Cash Flow

$72.60M

Cash & ST Invst.

$7.10M

Total Debt

$67.64M

American Oriental Bioengineering Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2013YOY CHG

Revenue

$17.94M

-39.2%

Gross Profit

$3.11M

-51.9%

Gross Margin

17.33%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$0.03

N/A

Employees

3,719

N/A

Net Income

$21.18M

-210.8%

EBITDA

$16.01M

+2.6%

Quarterly Fundamentals

Name
Q3 2013YOY CHG

Net Cash

$89.54M

-119.6%

Accounts Receivable

$27.25M

-40.6%

Inventory

$20.52M

-25.5%

Long Term Debt

$5.06M

+786.0%

Short Term Debt

$87.71M

+31.6%

Return on Assets

-13.38%

N/A

Return on Invested Capital

-16.16%

N/A

Free Cash Flow

$30.80M

-647.0%

Operating Cash Flow

$17.05M

-531.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PPIICoenzyme-A Inc.
$0.00+0.00%
ENCWEnchanted World Inc.
$0.00+0.00%
CDXICardax, Inc.
$0.00+0.00%
NRTSFNobilis Health Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.55-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.00+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$78.50+0.02%
IBITiShares Bitcoin Trust
$39.28-0.02%

Questions About AOBI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.